Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients

National Center for Global Health and Medicine, Japan

Status: Unknown

Conditions: HIV Infection; Renal Tubular Disorder; Renal Function Disorder

Study type: Observational

Funder types: Other

Identifiers

NCT02256579

NCGM-G-001074-01

Details and patient eligibility

About

This study is to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.

Full description

An observational study to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.

Enrollment: 1,800 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HIV-infected patients in the NHTD -ACC cohort who are under cART or will start cART and can provide written informed consents.

Exclusion criteria

• HIV-infected patients who drop out of treatment within 6 months from the entry.